Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
Filed with HKEX · Stock code 2410 · · 10 pages · English
Summary by 6ix AI
It confirms the total authorized or registered share capital at the end of the month. The report also includes information on issued shares and public float sufficiency confirmation. The company confirms compliance with public float requirements as of the end of the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from TYK Medicines
- Form of proxy for the second extraordinary general meeting of 2026 to be held on Friday, October 16, 2026 and any adjournment thereof
- Notice of the second extraordinary general meeting of 2026
- (1) Re-election of the retiring directors; (2) proposed amendments to the articles of association; and (3) notice of the second extraordinary general meeting of 2026
- Lapse of subscription agreement in relation to the issue of h shares under general mandate
- Book closure period for 2026 second extraordinary general meeting
Later from TYK Medicines
- Poll results of 2026 second extraordinary general meeting held on October 16, 2026
- Articles of association
Follow TYK Medicines into a list and get an email when it puts out news.
Follow TYK Medicines